Compounds derived from ftalazin - 1 (2H) - ona, Selective inhibitors of Poly (ADP ribose) polymerase-1； Pharmaceutical composition that comprises； and its use for the treatment of cancer.
SRIVASTAVA BRIJESH K,DESAI RANJIT C.,PATEL PANKAJ R.
申请号：
CL2015001655
公开号：
CL2015001655A1
申请日:
2015.06.12
申请国别(地区):
CL
年份:
2015
代理人:
摘要：
The present invention relates to novel compounds of general formula (I), their stereoisomers, regioisomers, tautomeric forms and novel intermediates involved in their synthesis, their pharmaceutically acceptable salts, pharmaceutically acceptable solvates and pharmaceutical compositions containing them. The present invention also relates to a process of preparing novel compounds of general formula (I), their stereoisomers, regioisomers, their tautomeric forms, their pharmaceutically acceptable salts, pharmaceutically acceptable solvates, pharmaceutical compositions containing them, and novel intermediates involved in their synthesis.COMPUESTOS DERIVADOS DE FTALAZIN1(2H)-ONA CON ACTIVIDAD INHIBIDORA SELECTIVA DE POLI (ADP-RIBOSA) POLIMERASA 1； COMPOSICIÓN FARMACÉUTICA QUE LOS COMPRENDE Y USO EN EL TRATAMIENTO DEL CÁNCER.
